BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22818898)

  • 1. [Whole-body magnetic resonance imaging in a patient with an occult abdominal neuroblastoma and opsoclonus-myoclonus syndrome].
    Miras Azcón F; Culiañez Casas M; Pastor Pons E
    Radiologia; 2014; 56(6):e54-7. PubMed ID: 22818898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
    Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
    Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
    Storz C; Bares R; Ebinger M; Handgretinger R; Tsiflikas I; Schäfer JF
    BMC Med Imaging; 2019 Aug; 19(1):70. PubMed ID: 31429709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
    Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
    Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
    Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
    Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome.
    Brunklaus A; Pohl K; Zuberi SM; de Sousa C
    Arch Dis Child; 2012 May; 97(5):461-3. PubMed ID: 21460401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The opsoclonus–myoclonus syndrome.
    Sahu JK; Prasad K
    Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
    Gupta A; Kundal R; Pandey M
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
    Chang BH; Koch T; Hopkins K; Malempati S
    Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
    Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
    Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsoclonus-myoclonus syndrome.
    Pike M
    Handb Clin Neurol; 2013; 112():1209-11. PubMed ID: 23622330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (acth).
    McGarvey CK; Applegate K; Lee ND; Sokol DK
    J Child Neurol; 2006 Jul; 21(7):606-10. PubMed ID: 16970854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
    Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
    Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma].
    Ducrocq X; Petit J; Taillandier L; Dorvaux V; Anxionnat R; Plénat F; Vespignani H
    Presse Med; 1999 Feb; 28(7):330-3. PubMed ID: 10083874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
    Pranzatelli MR; Tate ED; McGee NR
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
    Bell J; Moran C; Blatt J
    Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
    Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
    Singhi P; Sahu JK; Sarkar J; Bansal D
    J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.